These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22635608)

  • 1. Postmortem levetiracetam (Keppra®) data from North Carolina.
    Bishop-Freeman SC; Kornegay NC; Winecker RE
    J Anal Toxicol; 2012 Jul; 36(6):422-8. PubMed ID: 22635608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overdose with levetiracetam: a case report and review of the literature.
    Larkin TM; Cohen-Oram AN; Catalano G; Catalano MC
    J Clin Pharm Ther; 2013 Feb; 38(1):68-70. PubMed ID: 22725831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmortem Metaxalone (Skelaxin®) Data from North Carolina.
    Bishop-Freeman SC; Miller A; Hensel EM; Winecker RE
    J Anal Toxicol; 2015 Oct; 39(8):629-36. PubMed ID: 26378137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of non-therapeutic levetiracetam ingestions--a poison center based study.
    Bodmer M; Monte AA; Kokko J; Yin S
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):366-9. PubMed ID: 21328633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of levetiracetam (Keppra) poisoning with clinical and toxicokinetic data.
    Barrueto F; Williams K; Howland MA; Hoffman RS; Nelson LS
    J Toxicol Clin Toxicol; 2002; 40(7):881-4. PubMed ID: 12507057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Drug Monitoring of Levetiracetam and Lamotrigine: Is There a Need?
    Naik GS; Kodagali R; Mathew BS; Thomas M; Prabha R; Mathew V; Fleming DH
    Ther Drug Monit; 2015 Aug; 37(4):437-44. PubMed ID: 25478905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
    Mink S; Muroi C; Seule M; Bjeljac M; Keller E
    Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An 11-year review of levetiracetam ingestions in children less than 6 years of age.
    Lewis JC; Albertson TE; Walsh MJ
    Clin Toxicol (Phila); 2014 Nov; 52(9):964-8. PubMed ID: 25283254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dramatic weight loss with levetiracetam.
    Gelisse P; Juntas-Morales R; Genton P; Hillaire-Buys D; Diaz O; Coubes P; Crespel A
    Epilepsia; 2008 Feb; 49(2):308-15. PubMed ID: 17825078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients.
    Spencer DD; Jacobi J; Juenke JM; Fleck JD; Kays MB
    Pharmacotherapy; 2011 Oct; 31(10):934-41. PubMed ID: 21950640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhabdomyolysis associated with levetiracetam administration.
    Di Lorenzo R; Li Y
    Muscle Nerve; 2017 Jul; 56(1):E1-E2. PubMed ID: 28039868
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study.
    Wheless JW; Clarke D; Hovinga CA; Ellis M; Durmeier M; McGregor A; Perkins F
    J Child Neurol; 2009 Aug; 24(8):946-51. PubMed ID: 19264738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam and topiramate poisoning: Two overdoses on those drugs with no lasting effects.
    Sarfaraz M; Syeda RH
    Drug Discov Ther; 2017 May; 11(2):115-117. PubMed ID: 28320983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous levetiracetam in children with seizures: a prospective safety study.
    Ng YT; Hastriter EV; Cardenas JF; Khoury EM; Chapman KE
    J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy.
    Obeid M; Pong AW
    Epilepsy Res; 2010 Sep; 91(1):101-5. PubMed ID: 20663645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ metabolism of levetiracetam in blood of patients with epilepsy.
    Patsalos PN; Ghattaura S; Ratnaraj N; Sander JW
    Epilepsia; 2006 Nov; 47(11):1818-21. PubMed ID: 17116020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam use in pregnancy.
    Longo B; Forinash AB; Murphy JA
    Ann Pharmacother; 2009 Oct; 43(10):1692-5. PubMed ID: 19690219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of levetiracetam after oral and intravenous administration of a single dose to clinically normal cats.
    Carnes MB; Axlund TW; Boothe DM
    Am J Vet Res; 2011 Sep; 72(9):1247-52. PubMed ID: 21879984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.